The researchers propose that DSIPs observed effects, particularly the selective increase in V3 and ADP/t without affecting VDNP, suggest that it does not stimulate the activity of respiratory chain enzymes or substrate transporters, as these would typically affect VDNP
Recommendations are individualized based on medical history, current medications, wellness goals, and clinical appropriateness
The complete approval process consists of five major stages: preclinical toxicology studies, Phase I human safety and tolerance testing, Phase II efficacy evaluation, Phase III large-scale controlled clinical trials, and GMP manufacturing site audits
AOD 9604 dosing The standard dosage for AOD 9604 is 250 to 500 micrograms per day, administered via subcutaneous injection, typically into the abdominal fat layer
You could also be experiencing a vitamin B12 deficiency, depression, or long COVID
Products are for research use only